The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

Sascha Meyer dos SantosInstitute for Clinical Pharmacology, J.W. Goethe University Hospital, Frankfurt, Germany, Correspondence[email protected]

Karina KuczkaInstitute for Clinical Pharmacology, J.W. Goethe University Hospital, Frankfurt, Germany,

Bettina Picard-WillemsInstitute for Clinical Pharmacology, J.W. Goethe University Hospital, Frankfurt, Germany,

Karen NelsonDepartment of Vascular and Endovascular Surgery, J.W. Goethe University Hospital, Frankfurt, Germany, and

Ute KlinkhardtMerck KGaA, Darmstadt, Germany

Sebastian HarderInstitute for Clinical Pharmacology, J.W. Goethe University Hospital, Frankfurt, Germany,

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

Citations (5)

Articles from other publishers (5)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date